In 2017, the Indiana State Department of Health reported an average of five drug-overdose deaths per day. Three out of every five deaths involved opioids.

Hamilton County suffers from a severe shortage of substance abuse treatment providers to aid in combatting these saddening statistics. Through most of 2019, there were only five facilities providing substance abuse services and three providing some medication-assisted treatment, according to the amfAR Opioid & Health Indicators Database.

CleanSlate’s new Noblesville addiction treatment center, located at 18051 River Road, Suite 101, hopes to bring some much-needed relief to patients suffering from addiction in this area. The center offers medication-assisted treatment and additional medical services such as vaccinations, lab services and detox. CleanSlate uses an integrated approach to fighting opioid and alcohol addictions using the highest quality, evidence-based practices.

?Addiction is a terrible disease that has unfortunately infiltrated our community with devastating consequences,? said Bill Becker, center manager for CleanSlate Noblesville. CleanSlate’s goal is to bring relief through expanding addiction treatment services in the area and helping people get access to related healthcare services to ensure they not only overcome addiction but also maintain a healthy lifestyle in the future.?

CleanSlate was founded in 2009 in response to the country’s growing opioid epidemic. Over the past decade, the company has treated more than 50,000 patients in 11 states. CleanSlate currently operates 19 centers in Indiana.

CleanSlate Noblesville is accepting new patients. Those interested should call the center at 317-674-0062 to schedule an appointment. For more information about CleanSlate, visit

For media inquiries, please contact Carol Lynn at

Carol Fite Lynn

Carol Fite Lynn is the Director of Communications for CleanSlate, a leading national medical group that provides outpatient medication-assisted treatment for the chronic disease of addiction, primarily alcohol and opioid use disorders.